This protocol is judged by an institutional assessment board, an impartial group that opinions any clinical trials involving humans. If a research consists of a Routine I drug, when the board approves the protocol as ethical, the researchers should make an application for an investigational new drug (IND) quantity from the FDA.Along with the doses